FDA — authorised 16 July 1969
- Marketing authorisation holder: PHARMICS
- Status: approved
FDA authorised Paremyd on 16 July 1969
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 July 1969; FDA authorised it on 30 January 1992.
PHARMICS holds the US marketing authorisation.